拜耳集团Bayer AG (BAYZF) 2018年年度报告「OTC」.pdf

1、2018Annual Report 2 Five-Year Summary Bayer Annual Report 2018Five-Year Summary 20142015201620172018Bayer Group(million)Sales 41,33946,08534,94335,01539,586EBITDA1 8,3159,5738,8018,56310,266EBITDA before special items 1 8,68510,2569,3189,2889,547EBITDA margin before special items(in%)1 21.022.326.72

2、6.524.1EBIT1 5,3956,2415,7385,9033,914EBIT before special items 1 5,8337,0606,8267,1306,480Income before income taxes 4,4145,2364,7734,5772,318Net income(from continuing and discontinued operations)3,4264,1104,5317,3361,695Earnings per share(from continuing and discontinued operations)()1 4.144.975.

3、448.291.80Core earnings per share(from continuing operations)()1 5.896.826.676.645.94Net cash provided by operating activities(from continuing and discontinued operations)5,8106,8909,0898,1347,917Net financial debt 19,61217,44911,7783,59535,679Capital expenditures(as per segment table)2 2,4842,5542,

4、6272,4182,564 Bayer AG Total dividend payment 1,8612,0672,2332,4022,611Dividend per share()2.252.502.702.802.80 Innovation Research and development expenses(million)3,5374,2744,4054,5045,246Ratio of R&D expenses to sales Pharmaceuticals(%)15.616.016.716.215.5Ratio of R&D expenses to sales Crop Scien

5、ce(%)10.310.711.711.713.0Employees in research and development3 13,90014,75314,21314,04117,275 Employees Number of employees 3(Dec.31)117,400116,60099,59299,820116,998Personnel expenses(including pension expenses)(million)9,69311,1769,4599,52811,548Proportion of employees with health insurance(%)969

6、6989898Fluctuation(voluntary/total)(%)4.8/11.45.0/13.94.8/13.24.8/10.45.4/14.4Hours of vocational and ongoing training per employee 18.020.023.023.417.1 Safety&Environmental Protection Recordable Incident Rate(RIR)for Bayer employees 4 0.440.430.400.450.39Loss of Primary Containment Incident Rate(Lo